These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 8595619)
1. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin. Bozzo J; Hernández MR; Ordinas A Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619 [TBL] [Abstract][Full Text] [Related]
2. [Erythrocytes modulate the anti-aggregation effect of aspirin and dipyridamole. Study under static conditions and in a flow system]. Bozzo J; Hernández MR; Ordinas A Sangre (Barc); 1996 Feb; 41(1):13-8. PubMed ID: 8779028 [TBL] [Abstract][Full Text] [Related]
3. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro. Starzyk D; Korbut R; Gryglewski RJ J Physiol Pharmacol; 1999 Dec; 50(4):629-37. PubMed ID: 10639013 [TBL] [Abstract][Full Text] [Related]
4. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man. Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709 [TBL] [Abstract][Full Text] [Related]
5. Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes. Muravyov AV; Tikhomirova IA; Maimistova AA; Bulaeva SV Clin Hemorheol Microcirc; 2009; 43(3):223-32. PubMed ID: 19923692 [TBL] [Abstract][Full Text] [Related]
6. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients. Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924 [TBL] [Abstract][Full Text] [Related]
7. The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs. Yamamoto N; Yokota K; Yamashita A; Oda M Thromb Haemost; 1995 Jan; 73(1):118-21. PubMed ID: 7740482 [TBL] [Abstract][Full Text] [Related]
8. [Comparative efficiency of 1 direct and 2 indirect methods for the detection of differences in erythrocyte aggregation, in normal blood and in blood with echinocytosis]. Bozzo J; Hernández MR; Ordinas A Sangre (Barc); 1997 Jun; 42(3):165-9. PubMed ID: 9381256 [TBL] [Abstract][Full Text] [Related]
9. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats. Korbut R; Gryglewski RJ J Physiol Pharmacol; 1996 Dec; 47(4):591-9. PubMed ID: 9116326 [TBL] [Abstract][Full Text] [Related]
10. [Potentiation of the antiplatelet effect of dipyridamole and aspirin by erythrocytes. Study under flow conditions]. Bozzo J; Hernández MR; Bastida E; Escolar G; Ordinas A Sangre (Barc); 1993 Aug; 38(4):273-7. PubMed ID: 8235940 [TBL] [Abstract][Full Text] [Related]
11. Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy. Bhavsar J; Rosenson RS Clin Hemorheol Microcirc; 2010; 44(3):193-205. PubMed ID: 20364065 [TBL] [Abstract][Full Text] [Related]
12. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension]. Korbut RA; Adamek-Guzik T Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252 [TBL] [Abstract][Full Text] [Related]
13. Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. Carroll JS; Ku CJ; Karunarathne W; Spence DM Anal Chem; 2007 Jul; 79(14):5133-8. PubMed ID: 17580956 [TBL] [Abstract][Full Text] [Related]
14. Red blood cell deformability in diabetes mellitus: effect of phytomenadione. Sabo A; Jakovljević V; Stanulović M; Lepsanović L; Pejin D Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):1-5. PubMed ID: 8444511 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
16. Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity. Rosenson RS Microcirculation; 2008 Oct; 15(7):615-20. PubMed ID: 18788038 [TBL] [Abstract][Full Text] [Related]
17. Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy. Cecchi E; Marcucci R; Paniccia R; Bandinelli B; Valente S; Giglioli C; Lazzeri C; Gensini GF; Abbate R; Mannini L Am J Cardiol; 2009 Sep; 104(6):764-8. PubMed ID: 19733708 [TBL] [Abstract][Full Text] [Related]
18. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Barstad RM; Orvim U; Hamers MJ; Tjønnfjord GE; Brosstad FR; Sakariassen KS Thromb Haemost; 1996 May; 75(5):827-32. PubMed ID: 8725731 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonists. Peerschke EI; Silver RT; Weksler B; Grigg SE; Savion N; Varon D Br J Haematol; 2004 Oct; 127(2):195-203. PubMed ID: 15461626 [TBL] [Abstract][Full Text] [Related]
20. Impaired red blood cell deformability after oral administration of aspirin in man. Kovacs IB; O'Grady J Biomed Biochim Acta; 1984; 43(8-9):S395-8. PubMed ID: 6517905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]